Cancer Research Horizons appoints two investors-in-residence to support its Ventures team
Jonathan Tobin, a partner at life science venture capital firm Brandon Capital, and Genghis Lloyd-Harris, a senior advisor at life sciences investment firm, Abingworth, have joined Cancer Research Horizons’ Ventures […]
AI twice as accurate as a biopsy at grading aggressiveness of some sarcomas
Artificial intelligence (AI) could be around twice as accurate as a biopsy at grading the aggressiveness of some sarcomas, according to new research from The Royal Marsden NHS Foundation Trust and […]
Better use of existing drugs increases cervical cancer survival and reduces recurrence
A course of treatment with existing drugs prior to chemoradiation led to a 35 per cent reduction in the risk of death or return of cervical cancer, in trial results […]
Cutting-edge imaging sheds new light on cells that break down bone
Newly developed imaging technology shows that bone-resorbing osteoclasts gather in distinct pockets, leading to new insights for osteoporosis and cancer treatment. Bone may seem as if it’s a hard, lifeless […]
Study finds potential for treatment for pancreatic cancer using aggressive cells
A new collaborative study between King’s College London and Queen Mary University of London (QMUL) has identified cells that drive the spread of pancreatic cancer and discovered a weakness in […]
Significant gaps in public awareness of signs of cancer in children and young people
Only 32 per cent of adults felt confident in recognising cancer signs and symptoms in children, teenagers and young adults, according to newly published research. Funded by Children’s Cancer and […]
Scientists reverse drug resistance in prostate cancer by targeting ‘hijacked’ white blood cells
Prostate cancer’s resistance to treatment can be reversed in some patients by stopping hijacked white blood cells from being ‘pulled into’ tumours, according to new research published in Nature. In an […]
Secondary breast cancer patients may be spared routine scans
Women who have the most common form of secondary breast cancer and are doing well on treatment may be able to have their cancer monitored with a simple blood test […]
Researchers gain insights into chromosome shortening and identify potential cancer drug targets
A new study has provided insights into an important biological mechanism that supports survival of aggressive, hard-to-treat cancers – and in the process, researchers uncovered fascinating new information about how […]
New MedTech firm expands liquid biopsy research at The London Cancer Hub’s Innovation Gateway
Vortex Biosciences is expanding its footprint at The London Cancer Hub’s Innovation Gateway in support of its next phase of growth, having opened a new laboratory there earlier this year. The company […]
